John L Higgins's Net Worth
John L Higgins's net worth is estimated to be at least $50,527,513.85 as of 11/09/2024. CoreStreet's estimation of John L Higgins's net worth is based on their sale of stock and current holding of stock.
John L Higgins is Director at OmniAb Inc.. They have executed at least 33 trades of stock as per SEC Form 4 filings. Their most recent trade was for 9,000 units of OABI stock on 05/23/2023. Their biggest sale was on 08/17/2018 when they sold 34,500 units of Ligand Pharmaceuticals Incorporated stock for $8,347,620.00. They typically trade 3 times per year.
Total value of insider buys:
- $837,087.50
Total value of insider sells:
- $49,690,426.35
Most recent insider trade:
- May 23, 2023
John L Higgins's Insider Trading History
| OmniAb Inc. | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
May 23, 2023 | Director | 9,000 | $4.05 | Sell | $36,450.00 |
May 18, 2023 | Director | 50,000 | $3.89 | Sell | $194,500.00 |
| Ligand Pharmaceuticals Incorporated | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 16, 2022 | Director | 10,000 | $61.87 | Sell | $618,700.00 |
Nov. 17, 2022 | CEO | 10,000 | $78.32 | Sell | $783,200.00 |
Sept. 15, 2022 | CEO | 2,000 | $90.00 | Sell | $180,000.00 |
Nov. 12, 2021 | CEO | 3,000 | $160.50 | Sell | $481,500.00 |
Jan. 27, 2021 | CEO | 40,000 | $182.00 | Sell | $7,280,000.00 |
Jan. 25, 2021 | CEO | 50,000 | $159.00 | Sell | $7,950,000.00 |
July 31, 2019 | CEO | 1,850 | $95.45 | Buy | $176,582.50 |
May 14, 2019 | CEO | 2,500 | $113.50 | Buy | $283,750.00 |
March 13, 2019 | CEO | 2,500 | $114.29 | Buy | $285,725.00 |
Aug. 30, 2018 | CEO | 3,500 | $258.25 | Sell | $903,875.00 |
Aug. 17, 2018 | CEO | 34,500 | $241.96 | Sell | $8,347,620.00 |
May 15, 2018 | CEO | 12,405 | $179.97 | Sell | $2,232,527.85 |
Feb. 15, 2018 | CEO | 9,000 | $157.03 | Sell | $1,413,270.00 |
Jan. 24, 2018 | CEO | 22,500 | $165.00 | Sell | $3,712,500.00 |
Jan. 19, 2018 | CEO | 28,099 | $153.70 | Sell | $4,318,816.30 |
Nov. 16, 2017 | CEO | 5,269 | $142.53 | Sell | $750,990.57 |
Sept. 5, 2017 | CEO | 5,000 | $130.00 | Sell | $650,000.00 |
Aug. 8, 2017 | CEO | 5,483 | $125.00 | Sell | $685,375.00 |
June 21, 2017 | CEO | 4,666 | $120.00 | Sell | $559,920.00 |
June 9, 2017 | CEO | 12,000 | $114.87 | Sell | $1,378,440.00 |
March 20, 2017 | CEO | 4,000 | $109.10 | Sell | $436,400.00 |
Sept. 22, 2016 | CEO | 3,000 | $117.34 | Sell | $352,020.00 |
March 7, 2016 | CEO | 10,833 | $102.47 | Sell | $1,110,057.51 |
June 9, 2015 | CEO | 10,000 | $92.88 | Sell | $928,800.00 |
Aug. 15, 2014 | CEO | 1,000 | $54.97 | Buy | $54,970.00 |
Oct. 18, 2013 | CEO | 10,000 | $55.00 | Sell | $550,000.00 |
Dec. 5, 2012 | CEO | 2,000 | $18.03 | Buy | $36,060.00 |
| Bio-Techne Corp | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Aug. 10, 2022 | Director | 1,992 | $377.11 | Sell | $751,203.12 |
June 4, 2019 | Director | 5,000 | $203.67 | Sell | $1,018,350.00 |
Aug. 23, 2018 | Director | 10,000 | $187.92 | Sell | $1,879,200.00 |
Sept. 8, 2016 | Director | 1,700 | $109.83 | Sell | $186,711.00 |